TCON - TRACON Pharmaceuticals Inc. (TCON) Q1 2024 Earnings Call Transcript
2024-05-14 20:48:10 ET
TRACON Pharmaceuticals, Inc. (TCON)
Q1 2024 Earnings Conference Call
May 14, 2024 04:30 PM ET
Company Participants
Charles Theuer - President & CEO
Scott Brown - CFO
Conference Call Participants
Matthew Venezia - Alliance Global Partners
Presentation
Operator
Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers’ prepared remarks, we will conduct a question-and-answer session and instructions will be given at that time.
During today's call, we will be making certain forward-looking statements including statements regarding expected timing of clinical trials and results, regulatory activities, plans for future clinical trials, financing opportunities, our development plans and strategies, potential cost savings and other benefits deliverable through our product development platform or PDP, ability to enter into additional licensing agreements, ability to generate non-dilutive capital using the PDP, market size estimates and whether the company's stock will remain listed on NASDAQ....
TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript